Reproductive Biology and Endocrinology, published by BMC, is a distinguished open-access journal established in 2003, catering to researchers and professionals in the interdisciplinary fields of reproductive biology, endocrinology, and related biomedical sciences. With a notable impact in 2023, the journal has achieved Q1 rankings in Obstetrics and Gynecology, Reproductive Medicine, and Endocrinology, alongside a Q2 ranking in Developmental Biology, establishing itself as a pivotal source of high-quality research and insights. The journal's commitment to freely accessible research promotes knowledge dissemination across its domains, which is crucial for advancing understanding of reproductive health and endocrine mechanisms. With a robust Scopus ranking showcasing its relevance—17th out of 209 in Obstetrics and Gynecology, and 8th out of 90 in Reproductive Medicine—it serves as an essential resource for academics and clinicians alike, facilitating innovative research and fostering collaboration within the global scientific community.

Welcome to the Turkish Journal of Obstetrics and Gynecology, a premier publication dedicated to advancing the field of reproductive health and women's care. Published by GALENOS PUBL HOUSE since 2004, this journal serves as an essential resource for researchers, clinicians, and students interested in the latest developments in obstetrics and gynecology. With an impact factor that reflects its growing influence, the journal is currently classified in the Q3 quartile within its category, ranking 114 out of 209 in Scopus, placing it in the 45th percentile. Offering a truly Open Access platform, it provides a global audience with immediate access to critical research findings. The journal encompasses a broad scope of topics aimed at improving health outcomes for women, with a focus on evidence-based practice. In recent years, from 2016 to 2024, it has significantly contributed to the regional and international discourse in the field, making it an invaluable resource for practitioners and scholars alike. Join us in exploring the vital issues and innovations shaping obstetrics and gynecology today.

Reproductive Biomedicine Online, published by Elsevier, is a leading peer-reviewed journal that has established itself as a pivotal resource in the fields of Developmental Biology, Obstetrics and Gynecology, and Reproductive Medicine. With an impressive Impact Factor and a Q1 ranking in its respective disciplines as of 2023, this journal provides a platform for innovative research and comprehensive reviews that contribute to advancements in reproductive healthcare. The journal boasts rigorous Scopus rankings, placing it within the top tiers of its categories, which underscores its significance in shaping contemporary biomedical inquiry. Although not open access, it remains widely accessible through institutional subscriptions, making its wealth of knowledge available to researchers, clinicians, and students alike. Since its inception in 2000, Reproductive Biomedicine Online has been committed to fostering a deeper understanding of reproductive processes and biomedicine, ensuring that its content remains relevant and impactful in addressing challenges in reproductive health, thereby championing exceptional scientific discourse.

Journal of Men's Health, published by MRE PRESS, is a leading open-access journal dedicated to advancing research in the field of men's health and urology. Since its inception in 2008, this journal has provided a vital platform for interdisciplinary research, emphasizing the unique health issues affecting men. With an E-ISSN of 1875-6859, the journal has established a strong presence in the academic community, proudly achieving an open access model since 2015, which enhances accessibility for researchers and practitioners worldwide. As of 2023, it holds a Q4 ranking in Medicine (miscellaneous) and a Q3 ranking in Urology, underscoring its commitment to disseminating high-quality research amidst an evolving medical landscape. Positioned in Singapore, the Journal of Men's Health not only aims to foster knowledge exchange among professionals and scholars but also seeks to promote innovative solutions that address men's health challenges, making it a crucial resource for both existing and emerging health practitioners and researchers.

Aging Male is an esteemed peer-reviewed journal published by Taylor & Francis Ltd, dedicated to the multidisciplinary field of geriatrics and gerontology. With an impressive impact factor, this journal ranks in the top quartile (Q2) of its categories, solidifying its reputation as a leading source of research and insights for professionals and academics in the field. Since transitioning to Open Access in 2021, Aging Male has broadened its reach, facilitating the dissemination of relevant research findings that address the complexities of aging in male populations globally. The journal accepts a wide range of contributions, including original research, reviews, and clinical studies, with particular emphasis on the biological, psychological, and social aspects of male aging. Researchers, clinicians, and students alike will find this journal an invaluable resource for advancing knowledge and practice in the dynamic landscape of geriatric medicine.

Journal of Sexual Medicine, published by Oxford University Press, is a leading academic journal dedicated to advancing knowledge in the multifaceted field of sexual health and medicine. With an ISSN of 1743-6095 and E-ISSN of 1743-6109, this journal has established a solid reputation, achieving impressive rankings in multiple categories as evidenced by its Q1 status in Reproductive Medicine and Obstetrics and Gynecology, as well as Q2 status across several other related fields such as Endocrinology and Psychiatry. With a convergence spanning two decades (from 2004 to 2024), it serves as a critical platform for the dissemination of research findings, clinical insights, and innovative perspectives, embodying a commitment to evidence-based practice in sexual medicine. Although it follows a subscription model for access, the journal continues to engage a diverse array of researchers, clinicians, and students eager to explore the complexities of human sexual health.

Translational Andrology and Urology is a premier journal published by AME Publishing Company, dedicated to advancing research in the fields of reproductive medicine and urology. Established in 2012 and gaining prominence with its Q2 rankings in both the reproductive medicine and urology categories as of 2023, this journal serves as a vital platform for disseminating groundbreaking studies and clinical advancements. With an ISSN of 2223-4683 and an E-ISSN of 2223-4691, it is indexed in Scopus, standing at a distinguished rank of #40/120 in Urology and #33/90 in Reproductive Medicine. Located in Hong Kong, the journal reflects a commitment to open access and international collaboration, providing researchers, professionals, and students with critical insights and updates in these dynamic fields. As a leading resource, Translational Andrology and Urology invites contributions that explore innovative approaches that can enhance patient care and clinical practices.

ASIAN JOURNAL OF ANDROLOGY, published by Wolters Kluwer Medknow Publications, is a leading Open Access journal in the fields of urology and andrology. Since its inception in 1999, this journal has been instrumental in disseminating pivotal research that advances understanding and promotes progress within these specialty areas. With an impressive impact factor and a Scopus ranking of #27 out of 120 in Medicine (Urology), it is recognized for its contributions to both academia and clinical practice. The journal serves as a vital platform for researchers, professionals, and students interested in the latest findings and developments in male reproductive health and related fields, making it a key resource for anyone striving to enhance their knowledge and expertise. Based in India, the ASIAN JOURNAL OF ANDROLOGY is committed to fostering global discussions and collaborations that bind the scientific community together in the quest for innovation and improved patient outcomes.

Middle East Fertility Society Journal is a premier open-access publication established in 1996 that caters to the fields of Obstetrics and Gynecology as well as Reproductive Medicine. Published by SPRINGER in Egypt, this journal has made significant strides in disseminating high-quality research and advancements in reproductive health, achieving a 2023 Scopus rank of #102 in Obstetrics and Gynecology and #47 in Reproductive Medicine, placing it in the 51st and 48th percentiles respectively. With an aim to foster collaboration and innovation in the fertility sector, it welcomes researchers and practitioners to share their findings and insights, contributing to the global discourse on reproductive issues. As an open-access journal since 2010, it ensures that the latest research is readily available to a broad audience, enhancing accessibility and knowledge transfer in the vital area of reproductive health.

Andrology, an esteemed journal published by WILEY, is dedicated to advancing the field of reproductive health and medicine. With an ISSN of 2047-2919, this journal spans critical topics in andrology, urology, and endocrinology, reflecting its strong commitment to scholarly excellence and innovation. As a Q1 ranked journal in both Reproductive Medicine and Urology, Andrology boasts impressive Scopus rankings, standing at 6th in Reproductive Medicine and 8th in Urology, placing it in the top 10% of its field. The journal is accessible as an Open Access platform, ensuring that valuable research findings are available to a broader audience. With significant impact evidenced by its categorization in Q2 for Endocrinology and Diabetes and Metabolism, Andrology serves as an essential resource for researchers, clinicians, and students alike, supporting the continued advancement of knowledge and practice in male reproductive health.